{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:08Z","timestamp":1790845508193,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01969","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T01:26:34Z","timestamp":1596763594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?"],"prefix":"10.3389","volume":"11","author":[{"given":"Chunfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/pathogens9020130","article-title":"Host factors affecting generation of immunity against porcine epidemic diarrhea virus in pregnant and lactating swine and passive protection of neonates","volume":"9","author":"Langel","year":"2020","journal-title":"Pathogens"},{"key":"B3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1101\/2020.02.13.945485","article-title":"Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins","volume":"583","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J Gen Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF01250299","article-title":"Effect of chloroquine on the growth of animal viruses","volume":"36","author":"Shimizu","year":"1972","journal-title":"Arch Gesamte Virusforsch."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1073\/pnas.78.6.3605","article-title":"Antihistaminics, local anesthetics, and other amines as antiviral agents","volume":"78","author":"Miller","year":"1981","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Chloroquine interferes with dengue-2 virus replication in U937 cells","volume":"58","author":"Farias","year":"2014","journal-title":"Microbiol Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J Gen Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","article-title":"Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice","volume":"24","author":"Li","year":"2017","journal-title":"EBioMed."},{"key":"B14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1101\/051268","article-title":"Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models","volume":"8","author":"Delvecchio","year":"2016","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1084\/jem.20170957","article-title":"Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice","volume":"214","author":"Cao","year":"2017","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15771","DOI":"10.1038\/s41598-017-15467-6","article-title":"Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis","volume":"7","author":"Shiryaev","year":"2017","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","article-title":"An evaluation of chloroquine as a broad-acting antiviral against hand, foot and mouth disease","volume":"149","author":"Tan","year":"2018","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3201\/eid2106.150176","article-title":"Lack of protection against ebola virus from chloroquine in mice and hamsters","volume":"21","author":"Falzarano","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11979","DOI":"10.1128\/JVI.01847-09","article-title":"Chloroquine administration does not prevent Nipah virus infection and disease in ferrets","volume":"83","author":"Pallister","year":"2009","journal-title":"J Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1750-2659.2007.00027.x","article-title":"Chloroquine is effective against influenza A virus in vitro but not in vivo","volume":"1","author":"Vigerust","year":"2007","journal-title":"Influenza Other Respir Viruses."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1590\/S0074-02762013000500010","article-title":"Chloroquine use improves dengue-related symptoms","volume":"108","author":"Borges","year":"2013","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/429343","article-title":"A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India","volume":"191","author":"Dunne","year":"2005","journal-title":"J Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1475-2875-13-458","article-title":"Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults","volume":"13","author":"Sagara","year":"2014","journal-title":"Malar J."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.20040758","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.07.20056424","article-title":"Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study)","author":"Borba","year":"2020","journal-title":"medRxiv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v10050268","article-title":"Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection","volume":"10","author":"Roques","year":"2018","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40249-017-0328-9","article-title":"Dengue-specific serotype related to clinical severity during the 2012\/2013 epidemic in centre of Brazil","volume":"6","author":"Rocha","year":"2017","journal-title":"Infect Dis Poverty."},{"key":"B36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3785\/j.issn.1008-9292.2020.03.03","article-title":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)","volume":"49","author":"Chen","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"B37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","article-title":"Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms","volume":"31","author":"Retsema","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e00394","DOI":"10.1128\/AAC.00394-19","article-title":"Azithromycin protects against Zika virus infection by upregulating virus-induced Type I and III interferon responses","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur Respir J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"31601","DOI":"10.18632\/oncotarget.16364","article-title":"Azithromycin augments rhinovirus-induced IFNbeta via cytosolic MDA5 in experimental models of asthma exacerbation","volume":"8","author":"Menzel","year":"2017","journal-title":"Oncotarget."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg Microbes Infect."},{"key":"B45","doi-asserted-by":"publisher","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog."},{"key":"B46","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1183\/09031936.00102014","article-title":"Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells","volume":"45","author":"Schogler","year":"2015","journal-title":"Eur Respir J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.18632\/aging.101633","article-title":"Azithromycin and Roxithromycin define a new family of \u201csenolytic\u201d drugs that target senescent human fibroblasts","volume":"10","author":"Ozsvari","year":"2018","journal-title":"Aging."},{"key":"B48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.18632\/aging.103001","article-title":"COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?","volume":"12","author":"Sargiacomo","year":"2020","journal-title":"Aging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1101\/2020.02.16.20023903","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-06028-z","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4269\/ajtmh.2006.74.407","article-title":"Lack of a pharmacokinetic interaction between azithromycin and chloroquine","volume":"74","author":"Cook","year":"2006","journal-title":"Am J Trop Med Hyg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2393-6-18","article-title":"Pregnancy outcome following gestational exposure to azithromycin","volume":"6","author":"Sarkar","year":"2006","journal-title":"BMC Pregnancy Childbirth."},{"key":"B54","doi-asserted-by":"publisher","first-page":"221 e1","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0157045","DOI":"10.1371\/journal.pone.0157045","article-title":"Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum Malaria infection in pregnant women in Africa: an open-label, randomized trial","volume":"11","author":"Kimani","year":"2016","journal-title":"PLoS ONE."},{"key":"B56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1043661802002384","article-title":"Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily","volume":"46","author":"Di Paolo","year":"2002","journal-title":"Pharmacol Res."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.26.20081059","article-title":"Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19","author":"Huang","year":"2020","journal-title":"medRxiv"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli","year":"2020","journal-title":"Med (NY)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1016\/j.ajo.2020.03.029","article-title":"COVID-19 and Chloroquine\/Hydroxychloroquine: is there ophthalmological concern?","volume":"213","author":"Marmor","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2048872612471215","article-title":"Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review","volume":"2","author":"Joyce","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jjcc.2019.05.002","article-title":"Cellular senescence in cardiac diseases","volume":"74","author":"Shimizu","year":"2019","journal-title":"J Cardiol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT Interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019. (COVID-19)","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/JCMA.0000000000000318","article-title":"Potential therapeutic agents against COVID-19: what we know so far","volume":"83","author":"Lu","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMp2003762","article-title":"Responding to Covid-19 - a once-in-a-century pandemic?","volume":"382","author":"Gates","year":"2020","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory. coronavirus","volume":"64","author":"Martinez","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T01:26:37Z","timestamp":1596763597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2020.01969"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01969","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"article-number":"1969"}}